Das ideale Antihypertensivum — Wunschdenken und Wirklichkeit
作者： D. Palm
DOI: 10.1007/978-3-663-20205-9_1
关键词:
摘要: Die Pharmakotherapie der Hypertonie hat in den vergangenen 30 Jahren geradezu atemberaubende Fortschritte gemacht. Nachdem die Risiken des hohen Blutdrucks hinsichtlich erhohter Morbiditat und Mortalitat (Ubersicht bei [25]) bekannt geworden waren, antihypertensive Beweis dafur erbracht, das eine Senkung erhohten Blutdruckwerte auch Risiko, Sekundarerkrankung zu erleiden, trotz Weiterbestehens Grundleidens senken vermag [26]).
springer.com
sci-hub.st 参考文章(58)
Barry J. Materson, James R. Oster, Ulrich F. Michael, Sanford M. Bolton, Zeb C. Burton, John E. Stambaugh, John Morledge, Dose response to chlorthalidone in patients with mild hypertension; Efficacy of a lower dose Clinical Pharmacology & Therapeutics. ,vol. 24, pp. 192- 198 ,(1978) , 10.1002/CPT1978242192
Sweet Cs, Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421). Federation proceedings. ,vol. 42, pp. 167- ,(1983)
T Baum, E J Sybertz, Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers Federation proceedings. ,vol. 42, pp. 176- 181 ,(1983)
Lionel H. Opie, Calcium antagonists and cardiovascular disease Raven Press. ,(1984)
Lars Wilhelmsen, Göran Berglund, Dag Elmfeldt, Hans Wedel, β-Blockers versus saluretics in hypertension Preventive Medicine. ,vol. 10, pp. 38- 49 ,(1981) , 10.1016/0091-7435(81)90004-9
F Gross, Can we develop new drugs for hypertension British Journal of Clinical Pharmacology. ,vol. 13, pp. 133- 136 ,(1982) , 10.1111/J.1365-2125.1982.TB01348.X
Robert C. Tarazi, Harriet P. Dustan, Beta adrenergic blockade in hypertension The American Journal of Cardiology. ,vol. 29, pp. 633- 640 ,(1972) , 10.1016/0002-9149(72)90164-6
CT Dollery, A clinician looks at the future. British Journal of Clinical Pharmacology. ,vol. 13, pp. 127- 132 ,(1982) , 10.1111/J.1365-2125.1982.TB01347.X
Richard P. Ames, Peter Hill, Antihypertensive therapy and the risk of coronary heart disease. Journal of Cardiovascular Pharmacology. ,vol. 4, ,(1982) , 10.1097/00005344-198200042-00005
Ralph Cutler, Effect of antihypertensive agents on lipid metabolism American Journal of Cardiology. ,vol. 51, pp. 628- 631 ,(1983) , 10.1016/S0002-9149(83)80199-4